RhumbLine Advisers’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Buy
137,496
+8,621
+7% +$119K ﹤0.01% 1989
2026
Q1
$1.9M Sell
128,875
-4,136
-3% -$67.6K ﹤0.01% 1884
2025
Q4
$1.71M Sell
133,011
-21,400
-14% -$227K ﹤0.01% 1954
2025
Q3
$1.3M Sell
154,411
-5,019
-3% -$47.3K ﹤0.01% 2107
2025
Q2
$1.37M Buy
159,430
+6,443
+4% +$47.9K ﹤0.01% 2091
2025
Q1
$1.32M Buy
152,987
+6,081
+4% +$43.3K ﹤0.01% 2038
2024
Q4
$983K Sell
146,906
-3,869
-3% -$28.7K ﹤0.01% 2258
2024
Q3
$1.08M Buy
150,775
+1,718
+1% +$15.8K ﹤0.01% 2227
2024
Q2
$1.55M Buy
149,057
+1,953
+1% +$19.5K ﹤0.01% 2019
2024
Q1
$1.48M Buy
147,104
+3,849
+3% +$41.4K ﹤0.01% 2060
2023
Q4
$2.19M Sell
143,255
-123
-0.1% -$1.7K ﹤0.01% 1854
2023
Q3
$2.01M Buy
143,378
+375
+0.3% +$5.67K ﹤0.01% 1855
2023
Q2
$1.89M Sell
143,003
-1,460
-1% -$19.9K ﹤0.01% 1935
2023
Q1
$2.33M Buy
144,463
+5,082
+4% +$89.9K ﹤0.01% 1721
2022
Q4
$2.07M Buy
139,381
+1,476
+1% +$25.7K ﹤0.01% 1767
2022
Q3
$2.74M Buy
137,905
+9,817
+8% +$243K ﹤0.01% 1598
2022
Q2
$2.62M Buy
128,088
+42,837
+50% +$1.06M ﹤0.01% 1624
2022
Q1
$2.59M Sell
85,251
-11,493
-12% -$449K ﹤0.01% 1681
2021
Q4
$3.96M Buy
96,744
+564
+0.6% +$23.5K ﹤0.01% 1505
2021
Q3
$4.08M Sell
96,180
-7,972
-8% -$394K 0.01% 1473
2021
Q2
$5.49M Buy
104,152
+8,673
+9% +$431K 0.01% 1375
2021
Q1
$4.24M Sell
95,479
-4,960
-5% -$245K 0.01% 1500
2020
Q4
$4.83M Sell
100,439
-872
-0.9% -$42.1K 0.01% 1376
2020
Q3
$4.73M Sell
101,311
-8,795
-8% -$432K 0.01% 1207
2020
Q2
$4.95M Buy
110,106
+5,389
+5% +$209K 0.01% 1223
2020
Q1
$3.05M Buy
104,717
+19,452
+23% +$724K 0.01% 1313
2019
Q4
$4.07M Buy
85,265
+1,244
+1% +$53.9K 0.01% 1375
2019
Q3
$3.18M Sell
84,021
-76
-0.1% -$2.97K 0.01% 1456
2019
Q2
$3.6M Sell
84,097
-5,479
-6% -$259K 0.01% 1384
2019
Q1
$4.75M Sell
89,576
-15,866
-15% -$911K 0.01% 1208
2018
Q4
$6.22M Sell
105,442
-116
-0.1% -$6.4K 0.01% 974
2018
Q3
$5.76M Sell
105,558
-4,180
-4% -$231K 0.01% 1022
2018
Q2
$5.89M Sell
109,738
-23,990
-18% -$1.26M 0.01% 992
2018
Q1
$6.52M Sell
133,728
-10,788
-7% -$458K 0.01% 880
2017
Q4
$4.89M Sell
144,516
-7,118
-5% -$249K 0.01% 1080
2017
Q3
$5.14M Sell
151,634
-4,706
-3% -$161K 0.01% 1014
2017
Q2
$5.58M Sell
156,340
-17,854
-10% -$602K 0.01% 940
2017
Q1
$5.06M Buy
174,194
+6,242
+4% +$174K 0.01% 999
2016
Q4
$4.04M Buy
167,952
+13,516
+9% +$369K 0.01% 1048
2016
Q3
$4.79M Buy
154,436
+4,128
+3% +$130K 0.01% 909
2016
Q2
$4.4M Buy
150,308
+13,358
+10% +$400K 0.01% 881
2016
Q1
$4.21M Buy
136,950
+3,820
+3% +$98.6K 0.01% 918
2015
Q4
$3.57M Sell
133,130
-834
-0.6% -$23.2K 0.01% 1003
2015
Q3
$3.65M Buy
133,964
+3,862
+3% +$106K 0.01% 969
2015
Q2
$3.58M Sell
130,102
-1,290
-1% -$31.2K 0.01% 1042
2015
Q1
$2.81M Buy
131,392
+4,260
+3% +$72.7K 0.01% 1179
2014
Q4
$2.4M Sell
127,132
-5,140
-4% -$110K 0.01% 1229
2014
Q3
$2.89M Sell
132,272
-60,666
-31% -$1.62M 0.01% 1075
2014
Q2
$6.23M Sell
192,938
-15,240
-7% -$467K 0.02% 693
2014
Q1
$5.96M Buy
208,178
+6,592
+3% +$218K 0.02% 732
2013
Q4
$7.93M Sell
201,586
-6,570
-3% -$228K 0.02% 592
2013
Q3
$7.26M Sell
208,156
-12,586
-6% -$389K 0.02% 633
2013
Q2
$4.98M Buy
+220,742
New +$4.7M 0.02% 772

Other funds holding HLF

RhumbLine Advisers's HLF Position: Q2 2026 in Review

RhumbLine Advisers increased its Herbalife (HLF) stake by 6.7% in Q2 2026, buying an estimated $119K and bringing the position to 137,496 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1989.

RhumbLine Advisers first reported a position in HLF in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.93M in Q4 2013. 234 funds tracked by Wall St. Rank hold HLF as of Q2 2026.

  • RhumbLine Advisers held 137,496 shares of Herbalife worth $1.81M as of Q2 2026.
  • RhumbLine Advisers bought 8,621 Herbalife shares in Q2 2026, an estimated $119K.
  • Herbalife made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1989 holding.
  • RhumbLine Advisers first reported a position in Herbalife in Q2 2013 and has held it in 53 quarters since.
  • RhumbLine Advisers's Herbalife position peaked at $7.93M in Q4 2013.
  • 234 funds tracked by Wall St. Rank held Herbalife as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.